GILD · News · 20261030N

Trodelvy and Livdelzi Demand

GILEAD SCIENCES, INC. · 2026-10-30 · Importance 10 · Surprise 6

Third-quarter reporting identified Trodelvy in metastatic breast cancer and Livdelzi in primary biliary cholangitis (PBC) among the products driving Gilead’s business growth. A separate report said Trodelvy and Livdelzi helped lead product sales growth. The reports provide no product-specific sales figures or market-share data.